Utility of CT radiomics for prediction of PD-L1 expression in advanced lung adenocarcinomas

被引:69
|
作者
Yoon, Jiyoung [1 ]
Suh, Young Joo [1 ]
Han, Kyunghwa [1 ]
Cho, Hyoun [1 ]
Lee, Hye-Jeong [1 ]
Hur, Jin [1 ]
Choi, Byoung Wook [1 ]
机构
[1] Yonsei Univ, Severance Hosp, Coll Med, Res Inst Radiol Sci,Dept Radiol, Seoul, South Korea
关键词
Computed tomography; immunotherapy; lung adenocarcinoma; programmed death ligand 1; radiomics; FACTOR RECEPTOR MUTATION; DEATH LIGAND 1; EGFR MUTATION; INTERNATIONAL ASSOCIATION; COMPUTED-TOMOGRAPHY; TEXTURE ANALYSIS; STAGE-I; CANCER; CLASSIFICATION; FEATURES;
D O I
10.1111/1759-7714.13352
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Background We aimed to assess if quantitative radiomic features can predict programmed death ligand 1 (PD-L1) expression in advanced stage lung adenocarcinoma. Methods This retrospective study included 153 patients who had advanced stage (>IIIA by TNM classification) lung adenocarcinoma with pretreatment thin section computed tomography (CT) images and PD-L1 expression test results in their pathology reports. Clinicopathological data were collected from electronic medical records. Visual analysis and radiomic feature extraction of the tumor from pretreatment CT were performed. We constructed two models for multivariate logistic regression analysis (one based on clinical variables, and the other based on a combination of clinical variables and radiomic features), and compared c-statistics of the receiver operating characteristic curves of each model to identify the model with the higher predictability. Results Among 153 patients, 53 patients were classified as PD-L1 positive and 100 patients as PD-L1 negative. There was no significant difference in clinical characteristics or imaging findings on visual analysis between the two groups (P > 0.05 for all). Rad-score by radiomic analysis was higher in the PD-L1 positive group than in the PD-L1 negative group with a statistical significance (-0.378 +/- 1.537 vs. -1.171 +/- 0.822, P = 0.0008). A prediction model that uses clinical variables and CT radiomic features showed higher performance compared to a prediction model that uses clinical variables only (c-statistic = 0.646 vs. 0.550, P = 0.0299). Conclusions Quantitative CT radiomic features can predict PD-L1 expression in advanced stage lung adenocarcinoma. A prediction model composed of clinical variables and CT radiomic features may facilitate noninvasive assessment of PD-L1 expression. Key points Significant findings of the study Quantitative CT radiomic features can help predict PD-L1 expression, whereas none of the qualitative imaging findings is associated with PD-L1 positivity. What this study adds A prediction model composed of clinical variables and CT radiomic features may facilitate noninvasive assessment of PD-L1 expression.
引用
收藏
页码:993 / 1004
页数:12
相关论文
共 50 条
  • [21] Programmed Cell Death Ligand (PD-L1) Expression in Stage II and III Lung Adenocarcinomas and Nodal Metastases
    Uruga, Hironori
    Bozkurtlar, Emine
    Huynh, Tiffany G.
    Muzikansky, Alona
    Goto, Yasushi
    Gomez-Caraballo, Maria
    Hata, Aaron N.
    Gainor, Justin F.
    Mark, Eugene J.
    Engelman, Jeffrey A.
    Lanuti, Michael D.
    Mino-Kenudson, Mari
    JOURNAL OF THORACIC ONCOLOGY, 2017, 12 (03) : 458 - 466
  • [22] Outcome prediction in resectable lung adenocarcinoma patients: value of CT radiomics
    Choe, Jooae
    Lee, Sang Min
    Do, Kyung-Hyun
    Kim, Seonok
    Choi, Sehoon
    Lee, June-Goo
    Seo, Joon Beom
    EUROPEAN RADIOLOGY, 2020, 30 (09) : 4952 - 4963
  • [23] Factors correlating the expression of PD-L1
    Lu, Fang
    Wang, Ernuo
    Liu, Haiquan
    BMC CANCER, 2024, 24 (01)
  • [24] Comparative expression analysis of PD-1, PD-L1, and CD8A in lung adenocarcinoma
    Ma, Ke
    Qiao, Yulei
    Wang, Hao
    Wang, Shuai
    ANNALS OF TRANSLATIONAL MEDICINE, 2020, 8 (22)
  • [25] Evaluation of PD-L1 Expression Level in Patients With Non-Small Cell Lung Cancer by 18F-FDG PET/CT Radiomics and Clinicopathological Characteristics
    Li, Jihui
    Ge, Shushan
    Sang, Shibiao
    Hu, Chunhong
    Deng, Shengming
    FRONTIERS IN ONCOLOGY, 2021, 11
  • [26] Differential expression of PD-L1 and IDO1 in association with the immune microenvironment in resected lung adenocarcinomas
    Zhang, M. Lisa
    Kem, Marina
    Mooradian, Meghan J.
    Eliane, Jean-Pierre
    Huynh, Tiffany G.
    Iafrate, A. John
    Gainor, Justin F.
    Mino-Kenudson, Mari
    MODERN PATHOLOGY, 2019, 32 (04) : 511 - 523
  • [27] Correlation between PD-L1 expression and radiomic features in early-stage lung adenocarcinomas manifesting as ground-glass nodules
    Shi, Wenjia
    Yang, Zhen
    Zhu, Minghui
    Zou, Chenxi
    Li, Jie
    Liang, Zhixin
    Wang, Miaoyu
    Yu, Hang
    Yang, Bo
    Wang, Yulin
    Li, Chunsun
    Wang, Zirui
    Zhao, Wei
    Chen, Liang'an
    FRONTIERS IN ONCOLOGY, 2022, 12
  • [28] Radiomics study for predicting the expression of PD-L1 in non -small cell lung cancer based on CT images and clinicopathologic features
    Sun, Zongqiong
    Hu, Shudong
    Ge, Yuxi
    Wang, Jun
    Duan, Shaofeng
    Song, Jiayang
    Hu, Chunhong
    Li, Yonggang
    JOURNAL OF X-RAY SCIENCE AND TECHNOLOGY, 2020, 28 (03) : 449 - 459
  • [29] PD-L1 expression indicates favorable prognosis for advanced lung adenocarcinoma patients treated with pemetrexed
    Zhang, Pei
    Bao, Zhang
    Xu, Liming
    Zhou, Jianya
    Lu, Guohua
    Yao, Yinan
    Liu, Rong
    Gao, Qiqi
    Shen, Yihong
    Zhou, Jianying
    ONCOTARGET, 2017, 8 (39) : 66293 - 66304
  • [30] PD-L1 expression in neuroendocrine tumors of the lung
    Tsuruoka, Kenjiro
    Horinouchi, Hidehito
    Goto, Yasushi
    Kanda, Shintaro
    Fujiwara, Yutaka
    Nokihara, Hiroshi
    Yamamoto, Noboru
    Asakura, Keisuke
    Nakagawa, Kazuo
    Sakurai, Hiroyuki
    Watanabe, Shun-ichi
    Tsuta, Koji
    Ohe, Yuichiro
    LUNG CANCER, 2017, 108 : 115 - 120